Molecular Basis for Modulation of the p53 Target Selectivity by KLF4

被引:11
|
作者
Brandt, Tobias [1 ,2 ]
Townsley, Fiona M. [1 ]
Teufel, Daniel P. [1 ]
Freund, Stefan M. V. [1 ]
Veprintsev, Dmitry B. [1 ,3 ,4 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
[2] Max Planck Inst Biophys, D-6000 Frankfurt, Germany
[3] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland
[4] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland
来源
PLOS ONE | 2012年 / 7卷 / 10期
基金
英国医学研究理事会;
关键词
TUMOR-SUPPRESSOR P53; INTERACTING PROTEIN KINASE-2; DNA-BINDING SPECIFICITY; C-TERMINAL DOMAIN; TRANSACTIVATION SUBDOMAINS; CORE DOMAIN; COMPLEX; PHOSPHORYLATION; ACTIVATION; RADIATION;
D O I
10.1371/journal.pone.0048252
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tumour suppressor p53 controls transcription of various genes involved in apoptosis, cell-cycle arrest, DNA repair and metabolism. However, its DNA-recognition specificity is not nearly sufficient to explain binding to specific locations in vivo. Here, we present evidence that KLF4 increases the DNA-binding affinity of p53 through the formation of a loosely arranged ternary complex on DNA. This effect depends on the distance between the response elements of KLF4 and p53. Using nuclear magnetic resonance and fluorescence techniques, we found that the amino-terminal domain of p53 interacts with the KLF4 zinc fingers and mapped the interaction site. The strength of this interaction was increased by phosphorylation of the p53 N-terminus, particularly on residues associated with regulation of cell-cycle arrest genes. Taken together, the cooperative binding of KLF4 and p53 to DNA exemplifies a regulatory mechanism that contributes to p53 target selectivity.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] A Neat target of p53
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2017, 18 : 532 - 532
  • [22] p53 as a therapeutic target
    Staples, O. D.
    Steele, R. J. C.
    Lain, S.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2008, 6 (04): : 240 - 243
  • [23] Updates on p53: modulation of p53 degradation as a therapeutic approach
    Dey, A.
    Verma, C. S.
    Lane, D. P.
    BRITISH JOURNAL OF CANCER, 2008, 98 (01) : 4 - 8
  • [24] Updates on p53: modulation of p53 degradation as a therapeutic approach
    A Dey
    C S Verma
    D P Lane
    British Journal of Cancer, 2008, 98 : 4 - 8
  • [25] Mutant p53 rescue and modulation of p53 redox state
    Bykov, Vladimir J. N.
    Lambert, Jeremy M. R.
    Hainaut, Pierre
    Wiman, Klas G.
    CELL CYCLE, 2009, 8 (16) : 2509 - 2517
  • [26] Regulation of p53 function by KLF5
    Yang, Yizeng
    Zhou, Taicheng
    Zong, Zhen
    Lomberk, Gwen
    Urrutia, Raul
    Katz, Jonathan
    CANCER RESEARCH, 2015, 75
  • [27] p53 Basic C Terminus Regulates p53 Functions through DNA Binding Modulation of Subset of Target Genes
    Hamard, Pierre-Jacques
    Lukin, Dana J.
    Manfredi, James J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (26) : 22397 - 22407
  • [28] KLF4 is a FOXO target gene that suppresses B cell proliferation
    Yusuf, Isharat
    Kharas, Michael G.
    Chen, Jing
    Peralta, Raechel Q.
    Maruniak, Autumn
    Sareen, Pratibha
    Yang, Vincent W.
    Kaestner, Klaus H.
    Fruman, David A.
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (05) : 671 - 681
  • [29] ZNF750 is a p63 target that induces KLF4 to drive epidermal differentiation
    Sen, G. L.
    Boxer, L.
    Webster, D.
    Bussat, R.
    Qu, K.
    Zarnegar, B.
    Johnston, D.
    Siprashvili, Z.
    Khavari, P. A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S74 - S74
  • [30] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    Solomon, H.
    Sharon, M.
    Rotter, V.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1347 - 1349